Literature DB >> 11222777

Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration.

R M Cranenburgh1, J A Hanak, S G Williams, D J Sherratt.   

Abstract

We report the construction of two novel Escherichia coli strains (DH1lacdapD and DH1lacP2dapD) that facilitate the antibiotic-free selection and stable maintenance of recombinant plasmids in complex media. They contain the essential chromosomal gene, dapD, under the control of the lac operator/promoter. Unless supplemented with IPTG (which induces expression of dapD) or DAP, these cells lyse. However, when the strains are transformed with a multicopy plasmid containing the lac operator, the operator competitively titrates the LacI repressor and allows expression of dapD from the lac promoter. Thus transformants can be isolated and propagated simply by their ability to grow on any medium by repressor titration selection. No antibiotic resistance genes or other protein expressing sequences are required on the plasmid, and antibiotics are not necessary for plasmid selection, making these strains a valuable tool for therapeutic DNA and recombinant protein production. We describe the construction of these strains and demonstrate plasmid selection and maintenance by repressor titration, using the new pORT plasmid vectors designed to facilitate recombinant DNA exploitation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222777      PMCID: PMC29739          DOI: 10.1093/nar/29.5.e26

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  Recombinant protein production with minimal-antibiotic-resistance vectors.

Authors:  N Panayotatos
Journal:  Gene       Date:  1988-12-30       Impact factor: 3.688

2.  Pseudorevertants of a lac promoter mutation reveal overlapping nascent promoters.

Authors:  R Karls; V Schulz; S B Jovanovich; S Flynn; A Pak; W S Reznikoff
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

3.  Identification and genetic analysis of sbcC mutations in commonly used recBC sbcB strains of Escherichia coli K-12.

Authors:  R G Lloyd; C Buckman
Journal:  J Bacteriol       Date:  1985-11       Impact factor: 3.490

4.  Characterization of the operator sites of the exu regulon in Escherichia coli K-12 by operator-constitutive mutations and repressor titration.

Authors:  M Mata-Gilsinger; P Ritzenthaler; C Blanco
Journal:  Genetics       Date:  1983-12       Impact factor: 4.562

5.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

6.  The three operators of the lac operon cooperate in repression.

Authors:  S Oehler; E R Eismann; H Krämer; B Müller-Hill
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

7.  Deletion of an essential gene in Escherichia coli by site-specific recombination with linear DNA fragments.

Authors:  M Jasin; P Schimmel
Journal:  J Bacteriol       Date:  1984-08       Impact factor: 3.490

8.  Regulation of expression and nucleotide sequence of the Escherichia coli dapD gene.

Authors:  C Richaud; F Richaud; C Martin; C Haziza; J C Patte
Journal:  J Biol Chem       Date:  1984-12-10       Impact factor: 5.157

9.  Stability of a host-vector system based on complementation of an essential gene in Escherichia coli.

Authors:  E Degryse
Journal:  J Biotechnol       Date:  1991-04       Impact factor: 3.307

10.  Genetic analysis of diaminopimelic acid- and lysine-requiring mutants of Escherichia coli.

Authors:  A I Bukhari; A L Taylor
Journal:  J Bacteriol       Date:  1971-03       Impact factor: 3.490

View more
  31 in total

Review 1.  Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA.

Authors:  Juergen Mairhofer; Reingard Grabherr
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

2.  An LL-diaminopimelate aminotransferase defines a novel variant of the lysine biosynthesis pathway in plants.

Authors:  André O Hudson; Bijay K Singh; Thomas Leustek; Charles Gilvarg
Journal:  Plant Physiol       Date:  2005-12-16       Impact factor: 8.340

Review 3.  New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials.

Authors:  Gaëlle Vandermeulen; Corinne Marie; Daniel Scherman; Véronique Préat
Journal:  Mol Ther       Date:  2011-08-30       Impact factor: 11.454

Review 4.  Antibiotic-free selection in biotherapeutics: now and forever.

Authors:  Charlotte Mignon; Régis Sodoyer; Bettina Werle
Journal:  Pathogens       Date:  2015-04-03

5.  Novel antibiotic-free plasmid selection system based on complementation of host auxotrophy in the NAD de novo synthesis pathway.

Authors:  Wei-Ren Dong; Li-Xin Xiang; Jian-Zhong Shao
Journal:  Appl Environ Microbiol       Date:  2010-01-29       Impact factor: 4.792

6.  Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.

Authors:  Benedikt Asbach; Alexander Kliche; Josef Köstler; Beatriz Perdiguero; Mariano Esteban; Bertram L Jacobs; David C Montefiori; Celia C LaBranche; Nicole L Yates; Georgia D Tomaras; Guido Ferrari; Kathryn E Foulds; Mario Roederer; Gary Landucci; Donald N Forthal; Michael S Seaman; Natalie Hawkins; Steven G Self; Alicia Sato; Raphael Gottardo; Sanjay Phogat; James Tartaglia; Susan W Barnett; Brian Burke; Anthony D Cristillo; Deborah E Weiss; Jesse Francis; Lindsey Galmin; Song Ding; Jonathan L Heeney; Giuseppe Pantaleo; Ralf Wagner
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

7.  Antibiotic-free plasmid stabilization by operator-repressor titration for vaccine delivery by using live Salmonella enterica Serovar typhimurium.

Authors:  Helen S Garmory; Matthew W Leckenby; Kate F Griffin; Stephen J Elvin; Rosa R Taylor; M Gill Hartley; Julian A J Hanak; E Diane Williamson; Rocky M Cranenburgh
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 8.  Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

Authors:  James A Williams; Aaron E Carnes; Clague P Hodgson
Journal:  Biotechnol Adv       Date:  2009-02-20       Impact factor: 14.227

Review 9.  DNA vaccines: ready for prime time?

Authors:  Michele A Kutzler; David B Weiner
Journal:  Nat Rev Genet       Date:  2008-10       Impact factor: 53.242

10.  Factors affecting plasmid production in Escherichia coli from a resource allocation standpoint.

Authors:  Drew S Cunningham; Richard R Koepsel; Mohammad M Ataai; Michael M Domach
Journal:  Microb Cell Fact       Date:  2009-05-22       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.